Steen Lisby Y M Abs Therapeutics, Inc. (YMAB) insider trading activity

YMAB Quotes by TradingView

Steen Lisby is SVP & CHIEF SCIENTIFIC OFFICER of Y-mAbs Therapeutics, Inc.. Currently has a direct ownership of 35,600 shares of YMAB, which is worth approximately $294,768. The most recent transaction as insider was on Jan 18, 2024, when has been sold 17,800 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.6K
0% 3M change
100.0% 12M change
Total Value Held $294,768

Steen Lisby Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 18 2024
BUY
Grant, award, or other acquisition
-
17,800 Added 33.33%
35,600 Common Stock
Jan 17 2023
BUY
Grant, award, or other acquisition
-
17,800 Added 50.0%
17,800 Common Stock
SL

Steen Lisby

SVP & CHIEF SCIENTIFIC OFFICER
New York, NY

Track Institutional and Insider Activities on YMAB

Follow Y-mAbs Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMAB shares.

Notify only if

Insider Trading

Get notified when an Y M Abs Therapeutics, Inc. insider buys or sells YMAB shares.

Notify only if

News

Receive news related to Y-mAbs Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on YMAB